Julie K. Casteel, Chief Sales/Marketing Officer of IBEX Ltd, filed a Form 4 on November 3, 2026, disclosing a grant of 9,500 restricted stock units received on October 30, 2026.

Key Highlights

  • Grant date: The RSU award was made on October 30, 2026, at a reported price of $0.
  • Award size: Casteel received 9,500 restricted stock units, each representing a contingent right to one common share.
  • Vesting schedule: 25% of the RSUs vest annually over four years, beginning September 30, 2027, subject to continuous service.
  • Tax withholding: On each vesting date, the issuer will automatically withhold shares to satisfy tax withholding obligations in a non-discretionary transaction.
  • Beneficial ownership following transaction: Casteel directly holds 112,271 common shares following the reported transaction.
  • Filing agent: The form was signed by Lisa Lenstrohm as Attorney-in-Fact on November 3, 2026.

IBEX Ltd RSU Grant to Chief Sales/Marketing Officer Julie Casteel

According to the Form 4 filed with the SEC on November 3, 2026, Julie K. Casteel, serving as Chief Sales/Marketing Officer of IBEX Ltd (NASDAQ:IBEX), was granted 9,500 restricted stock units on October 30, 2026. The filing records the transaction as an acquisition (code "A") at a price of $0, consistent with an equity award rather than an open-market purchase.

The filing states that each RSU represents "a contingent right to receive one share of Issuer's Common Stock for each RSU." The vesting terms, as described in the filing's footnote, provide that 25% of the granted RSUs shall vest annually over four years, commencing on September 30, 2027, "provided that the Reporting Person remains in continuous service on each vesting date." The issuer will automatically withhold shares on each vesting date to cover the reporting person's tax withholding obligations, described as a non-discretionary transaction.

Following the reported grant, Casteel's direct beneficial ownership stands at 112,271 common shares of IBEX Ltd, as reported in Table I of the filing. No derivative securities transactions were reported in Table II.

What Was Disclosed

The filing disclosed an RSU award of 9,500 common shares to IBEX Ltd's Chief Sales/Marketing Officer on October 30, 2026, with four-year annual vesting beginning September 30, 2027, and resulting total direct ownership of 112,271 shares.